A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects with Diabetic Neuropathic Pain

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-024359-99

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare the analgesic efficacy and the safety of ABT-639 (100 mg capsules) administered twice daily to placebo in the treatment of diabetic neuropathic pain (DNP). Pregabalin 150 mg administered twice daily will be assessed for assay sensitivity.


Critère d'inclusion

  • Diabetic Neuropathic Pain